Drug factory · FDA FEI 3011090684
Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
2nd Luhui Rd, Kengzi Jinsha Community Pingshan District, Shenzhen, China
Problems found, fixed voluntarily at FDA's last inspection, Jun 26, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2026: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Liraglutide | Makes it | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 14403-3400 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jun 26, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.